Logo image of IVQ-U.CA

INVESQUE INC (IVQ-U.CA) Stock Fundamental Analysis

Canada - TSX:IVQ-U - CA46136U1030 - Common Stock

0.09 USD
0 (0%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

2

IVQ-U gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 29 industry peers in the Real Estate Management & Development industry. IVQ-U has a bad profitability rating. Also its financial health evaluation is rather negative. IVQ-U has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

IVQ-U had negative earnings in the past year.
IVQ-U had a negative operating cash flow in the past year.
IVQ-U had negative earnings in each of the past 5 years.
Each year in the past 5 years IVQ-U had a positive operating cash flow.
IVQ-U.CA Yearly Net Income VS EBIT VS OCF VS FCFIVQ-U.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of IVQ-U (-2.17%) is worse than 65.52% of its industry peers.
Looking at the Return On Equity, with a value of -5.38%, IVQ-U is doing worse than 62.07% of the companies in the same industry.
IVQ-U's Return On Invested Capital of 8.99% is amongst the best of the industry. IVQ-U outperforms 93.10% of its industry peers.
IVQ-U had an Average Return On Invested Capital over the past 3 years of 4.96%. This is significantly below the industry average of 11.82%.
The last Return On Invested Capital (8.99%) for IVQ-U is above the 3 year average (4.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.17%
ROE -5.38%
ROIC 8.99%
ROA(3y)-7.36%
ROA(5y)-7.06%
ROE(3y)-39.46%
ROE(5y)-37.07%
ROIC(3y)4.96%
ROIC(5y)3.58%
IVQ-U.CA Yearly ROA, ROE, ROICIVQ-U.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With a Operating Margin value of 17.58%, IVQ-U perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
IVQ-U's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 38.24%, IVQ-U perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
In the last couple of years the Gross Margin of IVQ-U has declined.
Industry RankSector Rank
OM 17.58%
PM (TTM) N/A
GM 38.24%
OM growth 3Y-11.85%
OM growth 5Y-19.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5Y-10.41%
IVQ-U.CA Yearly Profit, Operating, Gross MarginsIVQ-U.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IVQ-U is creating some value.
IVQ-U has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IVQ-U has been increased compared to 5 years ago.
Compared to 1 year ago, IVQ-U has an improved debt to assets ratio.
IVQ-U.CA Yearly Shares OutstandingIVQ-U.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
IVQ-U.CA Yearly Total Debt VS Total AssetsIVQ-U.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

IVQ-U has an Altman-Z score of -1.16. This is a bad value and indicates that IVQ-U is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.16, IVQ-U is not doing good in the industry: 93.10% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.57 indicates that IVQ-U is somewhat dependend on debt financing.
The Debt to Equity ratio of IVQ-U (0.57) is better than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -1.16
ROIC/WACC1.4
WACC6.41%
IVQ-U.CA Yearly LT Debt VS Equity VS FCFIVQ-U.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

IVQ-U has a Current Ratio of 1.15. This is a normal value and indicates that IVQ-U is financially healthy and should not expect problems in meeting its short term obligations.
IVQ-U has a Current ratio of 1.15. This is comparable to the rest of the industry: IVQ-U outperforms 44.83% of its industry peers.
IVQ-U has a Quick Ratio of 1.15. This is a normal value and indicates that IVQ-U is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.15, IVQ-U is in line with its industry, outperforming 44.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
IVQ-U.CA Yearly Current Assets VS Current LiabilitesIVQ-U.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

IVQ-U shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.64%, which is quite impressive.
The Revenue for IVQ-U has decreased by -17.64% in the past year. This is quite bad
Measured over the past years, IVQ-U shows a small growth in Revenue. The Revenue has been growing by 2.50% on average per year.
EPS 1Y (TTM)78.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.56%
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y-5.05%
Revenue growth 5Y2.5%
Sales Q2Q%-31.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVQ-U.CA Yearly Revenue VS EstimatesIVQ-U.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IVQ-U.CA Yearly EPS VS EstimatesIVQ-U.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

IVQ-U reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVQ-U.CA Price Earnings VS Forward Price EarningsIVQ-U.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

96.55% of the companies in the same industry are more expensive than IVQ-U, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.9
IVQ-U.CA Per share dataIVQ-U.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IVQ-U!.
Industry RankSector Rank
Dividend Yield N/A

INVESQUE INC

TSX:IVQ-U (10/10/2025, 7:00:00 PM)

0.09

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-06 2025-11-06
Inst Owners80.68%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap82.27M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.44
EV/EBITDA 6.9
EPS(TTM)-0.31
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.23
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -5.38%
ROCE 12.48%
ROIC 8.99%
ROICexc 9.47%
ROICexgc 9.47%
OM 17.58%
PM (TTM) N/A
GM 38.24%
FCFM N/A
ROA(3y)-7.36%
ROA(5y)-7.06%
ROE(3y)-39.46%
ROE(5y)-37.07%
ROIC(3y)4.96%
ROIC(5y)3.58%
ROICexc(3y)5.27%
ROICexc(5y)3.77%
ROICexgc(3y)5.27%
ROICexgc(5y)3.77%
ROCE(3y)6.89%
ROCE(5y)4.97%
ROICexcg growth 3Y49.36%
ROICexcg growth 5Y22.64%
ROICexc growth 3Y49.36%
ROICexc growth 5Y22.64%
OM growth 3Y-11.85%
OM growth 5Y-19.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.87%
GM growth 5Y-10.41%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 2.27
Cap/Depr 67.28%
Cap/Sales 3.2%
Interest Coverage 0.68
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z -1.16
F-Score5
WACC6.41%
ROIC/WACC1.4
Cap/Depr(3y)37.85%
Cap/Depr(5y)34.19%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%106.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.64%
Revenue growth 3Y-5.05%
Revenue growth 5Y2.5%
Sales Q2Q%-31.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.09%
EBIT growth 3Y-16.3%
EBIT growth 5Y-17.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-629.54%
FCF growth 3Y-26.54%
FCF growth 5YN/A
OCF growth 1Y-114.17%
OCF growth 3Y-20.82%
OCF growth 5Y-10.52%